ImmuCell Total Assets 2006-2018 | ICCC

ImmuCell total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
ImmuCell Annual Total Assets
(Millions of US $)
2017 $34
2016 $25
2015 $15
2014 $11
2013 $11
2012 $11
2011 $11
2010 $11
2009 $10
2008 $10
2007 $10
2006 $0
2005 $10
ImmuCell Quarterly Total Assets
(Millions of US $)
Q3 2018 $33
Q2 2018 $33
Q1 2018 $34
Q4 2017 $34
Q3 2017 $30
Q2 2017 $28
Q1 2017 $25
Q4 2016 $25
Q3 2016 $21
Q2 2016 $21
Q1 2016 $20
Q4 2015 $15
Q3 2015 $14
Q2 2015 $11
Q1 2015 $11
Q4 2014 $11
Q3 2014 $11
Q2 2014 $11
Q1 2014 $11
Q4 2013 $11
Q3 2013 $11
Q2 2013 $11
Q1 2013 $11
Q4 2012 $11
Q3 2012 $11
Q2 2012 $11
Q1 2012 $11
Q4 2011 $11
Q3 2011 $11
Q2 2011 $11
Q1 2011 $11
Q4 2010 $11
Q3 2010 $11
Q2 2010 $10
Q1 2010 $10
Q4 2009 $10
Q3 2009 $10
Q2 2009 $10
Q1 2009 $10
Q4 2008 $10
Q3 2008 $10
Q2 2008 $10
Q1 2008 $11
Q4 2007 $10
Q3 2007 $10
Q2 2007 $11
Q1 2007 $11
Q4 2006 $0
Q3 2006 $0
Q2 2006 $10
Q1 2006 $10
Q4 2005 $10
Q3 2005 $10
Q2 2005 $10
Q1 2005 $10
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.038B $0.011B
ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.447B 27.76
Medtronic (MDT) Ireland $124.271B 18.17
Stryker (SYK) United States $73.087B 26.83
Boston Scientific (BSX) United States $52.902B 25.79
Baxter (BAX) United States $39.768B 25.44
Zimmer Biomet Holdings (ZBH) United States $25.701B 16.45
Smith & Nephew SNATS (SNN) United Kingdom $17.481B 0.00
Canopy Growth (CGC) Canada $15.431B 0.00
ResMed (RMD) United States $14.029B 26.60
Aurora Cannabis (ACB) Canada $10.082B 71.14
Bio-Rad Laboratories (BIO) United States $9.411B 53.70
Hill-Rom Holdings (HRC) United States $6.960B 21.53
Perrigo (PRGO) Ireland $6.690B 10.85
Insulet (PODD) United States $5.859B 1976.60
GW Pharmaceuticals (GWPH) United Kingdom $5.071B 0.00
ICU Medical (ICUI) United States $4.915B 30.60
Haemonetics (HAE) United States $4.429B 39.29
Hutchison China MediTech (HCM) China $3.856B 0.00
Agios Pharmaceuticals (AGIO) United States $3.806B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.882B 25.14
Quidel (QDEL) United States $2.658B 23.98
Aphria (APHA) $2.606B 115.67
National Vision Holdings (EYE) United States $2.333B 45.89
HEXO (HEXO) $1.460B 0.00
Cardiovascular Systems (CSII) United States $1.372B 985.25
VAREX IMAGING (VREX) United States $1.306B 25.56
Phibro Animal Health (PAHC) United States $1.294B 18.60
AtriCure (ATRC) United States $1.108B 0.00
Lantheus Holdings (LNTH) United States $0.947B 25.58
MacroGenics (MGNX) United States $0.921B 0.00
Cerus (CERS) United States $0.868B 0.00
Omeros (OMER) United States $0.861B 0.00
PetIQ (PETQ) United States $0.815B 23.33
NanoString Technologies (NSTG) United States $0.755B 0.00
Evolus (EOLS) United States $0.725B 0.00
OraSure Technologies (OSUR) United States $0.713B 31.24
Meridian Bioscience (VIVO) United States $0.705B 21.00
Eagle Pharmaceuticals (EGRX) United States $0.680B 23.15
TG Therapeutics (TGTX) United States $0.653B 0.00
Surmodics (SRDX) United States $0.616B 89.55
LeMaitre Vascular (LMAT) United States $0.610B 29.03
Quanterix (QTRX) United States $0.550B 0.00
BioLife Solutions (BLFS) United States $0.376B 155.15
Insys Therapeutics (INSY) United States $0.358B 0.00
Rockwell Medical (RMTI) United States $0.357B 0.00
Vapotherm (VAPO) United States $0.335B 0.00
Utah Medical Products (UTMD) United States $0.313B 20.35
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.270B 0.00
Bovie Medical (APYX) United States $0.266B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.142B 0.00
Zynex (ZYXI) United States $0.142B 15.17
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.098B 0.00
United-Guardian (UG) United States $0.088B 18.33
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.087B 0.00
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
Neurotrope (NTRP) United States $0.056B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
NeuroMetrix (NURO) United States $0.008B 15.00